Expression of p53 and proliferation index as prognostic factors in gastrointestinal sarcomas

Annals of Surgical Oncology

Volumn 10, Issue 2, 2003, Pages 190-195

  Medina Franco, Heriberto ^a,d   Ramos De La Medina, Antonio ^a   Cortes Gonzalez, Ruben ^a   Baquera, Jorge ^a   Angeles Angeles, Arturo ^a   Urist, Marshal M ^b   Eltoum, Isam E ^c   Heslin, Martin J ^b  

^a National Institute of Medicine Sciences and Nutrition Salvador Subirán   (Mexico)

^b Kentucky   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d National Institute of Medical Science and Nutrition   (Mexico)

Author keywords

Gastrointestinal sarcoma; p53; Prognostic factors; Proliferation index

Indexed keywords

KI 67 ANTIGEN; PROTEIN P53; TUMOR MARKER;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANALYTIC METHOD; ANTIGEN EXPRESSION; ARTICLE; CANCER GRADING; CANCER SURGERY; CANCER SURVIVAL; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; FEMALE; FOLLOW UP; GASTROINTESTINE TRACT SARCOMA; HISPANIC; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PROGNOSIS; PROTEIN EXPRESSION; RACE DIFFERENCE; REGRESSION ANALYSIS; SCHOOL CHILD; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME; TUMOR VOLUME; UNIVERSITY HOSPITAL; GASTROINTESTINAL TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; PREDICTION AND FORECASTING; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK FACTOR; SARCOMA; SURVIVAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; KI-67 ANTIGEN; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SARCOMA; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0038622011     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1245/ASO.2003.03.033     Document Type: Article

References (26)

1. Medina-Franco H, Eltoum IE, Urist MM, Heslin MJ. Primary gastrointestinal sarcomas. Am Surg 2000;66:1-5.
2. Akwari OE, Dozois RR, Weiland LH, Beahrs OH. Leiomyosarcomas of the small and large bowel. Cancer 1978;42:1375-84.
3. Evans HL. Smooth muscle tumors of the gastrointestinal tract. Cancer 1985;58:2242-50.
4. Zollinger RM, Sternfeld WC, Schreiber H. Primary neoplasms of the small intestine. Am J Surg 1986;151:654-8.
5. McGrath PC, Neifield JP, Lawrence W Jr, et al. Gastrointestinal sarcomas: analysis of prognostic factors. Ann Surg 1987;206:706-10.
6. Dougherty MJ, Compton C, Talbert M, Wood WC. Sarcomas of the gastrointestinal tract: separation into favorable and unfavorable prognostic groups by mitotic count. Ann Surg 1991;214:569-74.
7. DeMatteo RP, Lewis JJ, Leung D, Mudan SS, Woodruff JM, Brennan MF. Two hundred gastrointestinal stromal tumors. Recurrence patterns and prognostic factors for survival. Ann Surg 2000;231:51-8.
8. Blanke CD, von Mehren M, Joensuu H, et al. Evaluation of the safety and efficacy of an oral molecularly-targeted therapy, STI571, in patients with unresectable or metastatic gastrointestinal stromal tumors (GISTS) expressing c-kit (CD117). Proc Am Soc Clin Oncol 2001;20:2.
9. Van Oosterom AT, Judson I, Verweij J, et al. STI571, an active drug in metastatic gastrointestinal stromal tumors (GIST), an EORTC phase I Study. Proc Am Soc Clin Oncol 2001;20:2.
10. Heslin MJ, Cordon-Cardo C, Lewis JJ, Woodruff JM, Brennan MF. Ki-67 detected by MIB-1 predicts distant metastasis and tumor mortality in primary, high-grade extremity soft tissue sarcoma. Cancer 1998;83:490-7.
11. Sanders L, Silverman M, Rossi R, Braasch J, Munson L. Gastric smooth muscle tumors: diagnostic dilemmas and factors affecting outcome. World J Surg 1996;20:992-5.
12. Ludwig DJ, Traverso LW. Gut stomal tumors and their clinical behavior. Am J Surg 1997;173:390-4.
13. Lewin KJ, Riddel RH, Weinstein WM, eds. Gastrointestinal Pathology and Its Clinical Implications. New York: Igaku-Shoin Medical Publishers, 1992:299-301.
14. Al-Jaberi TM, Al-Masri N, Tubukhi A. Adult rhabdomyosarcoma of the gallbladder: case report and review of published works. Gut 1994;35:854-6.
15. Conlon KC, Casper ES, Brennan MF. Primary gastrointestinal sarcomas: analysis of prognostic factors. Ann Surg Oncol 1995;2:26-31.
16. Ng EG, Pollock RE, Munsell MF, et al. Prognostic factors influencing survival in gastrointestinal leiomyosarcomas. Ann Surg 1992;215:68-77.
17. Daly MB, Clark GM, McGwire WM. Breast cancer prognosis in a mixed Caucasian-Hispanic population. J Natl Cancer Inst 1985;74:753-6.
18. Elledge RM, Clark GM, Chamness GC, et al. Tumor biologic factors and breast cancer prognosis among white, Hispanic and black women in the United States. J Natl Cancer Inst 1994;86:705-9.
19. Gordon NH, Crowe JP, Brumberg DJ, et al. Socioeconomic factors and race in breast cancer recurrence and survival. Am J Epidemiol 1992;135:609-15.
20. Gerdes J. Ki-67 and other proliferation markers useful for immunohistological diagnostic and prognostic evaluations in human malignancies. Semin Cancer Biol 1990;1:199-206.
21. Drobnjak M, Latres E, Pollack D, et al. Prognostic implications of p53 nuclear overexpression and high proliferation index of Ki-67 in adult soft tissue sarcomas. J Natl Cancer Inst 1994;86:549-54.
22. Choong PF, Akerman M, Willen H, et al. Prognostic value of Ki-67 expression in 182 soft tissue sarcomas. Proliferation - a marker of metastasis? APMIS 1994;102:915-24.
23. Reich NC, Oren M, Levine AJ. Two distinct mechanisms regulate the levels of a cellular tumor antigen, p53. Mol Cell Biol 1983;3:2143-50.
24. Cordon-Cardo C, Lares E, Drobnjak M, et al. Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas. Cancer Res 1994;54:794-9.
25. Leach FS, Tokino T, Meltzer P, et al. p53 mutation and MDM2 amplification in human soft tissue sarcomas. Cancer Res 1993;53(Suppl):2231-4.
26. Andreassen A, Oyjord T, Hovig E, et al. p53 abnormalities in different subtypes of human sarcomas. Cancer Res 1993;53:468-71.